BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
BECTON DICKINSON & CO
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$190.74−1.01 (-0.53%)
Close on Oct 19, 2026
- Market cap
- $52.48B
- P/E (TTM)
- 57.6
- Dividend yield
- 2.18%
BECTON DICKINSON & CO revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical | $11.46B | $10.07B | $9.50B | $8.84B | $8.36B | $7.64B | $9.06B | $8.62B | $7.42B | $7.97B | 52.5% | +13.7% |
| Interventional | $5.22B | $4.98B | $4.74B | $4.46B | $4.24B | $3.76B | $3.93B | $3.04B | $685.00M | $689.00M | 23.9% | +4.8% |
| Life Sciences | $5.17B | $5.19B | $5.13B | $5.56B | $6.53B | $4.68B | $4.30B | $4.33B | $3.99B | $3.83B | 23.7% | -0.5% |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical | $4.14B | $3.58B | $3.35B | – | – | – | – | – | – | – | +15.5% |
| Interventional | $2.25B | $2.12B | $1.94B | – | – | – | – | – | – | – | +6.5% |
| Life Sciences | $1.64B | $1.62B | $1.60B | – | – | – | – | – | – | – | +1.5% |
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U S [Member] | $12.79B | $11.66B | $11.11B | $10.72B | $10.37B | $9.16B | $9.73B | $8.77B | $6.50B | $6.89B | 58.6% | +9.7% |
| International | $9.05B | $8.52B | $8.26B | $8.15B | $8.76B | $6.91B | $7.56B | $7.22B | $5.59B | – | 41.4% | +6.3% |
| EMEA | $4.73B | $4.40B | $4.24B | $4.04B | $4.55B | $3.73B | $3.84B | – | – | – | 21.7% | +7.4% |
| Greater Asia | $3.09B | $2.91B | $2.91B | $3.05B | $3.07B | $2.38B | $2.73B | $2.46B | $1.74B | $1.69B | 14.2% | +6.4% |
| Other | $1.23B | $1.21B | $1.10B | $1.06B | $1.14B | $794.00M | $997.00M | $1.46B | $1.26B | $1.23B | 5.6% | +1.7% |
| Europe | – | – | – | – | – | $3.48B | $3.36B | $3.30B | $2.59B | $2.67B | – | – |
| Middle East and Africa | – | – | – | – | – | $448.00M | $478.00M | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Becton Dickinson's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.